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ABSTRACT
Introduction: Oral administration of arginine has been associat-
ed with physical performance improvement due to probable de-
crease of muscular fatigue derived from the vasodilatation factor
of the nitric oxide over the skeletal muscles. Objective: to evalu-
ate the effects of oral administration of L-Arginine during an exer-
cise program with weights. Methods: 20 male individuals, randomly
divided in two groups: A and B, were submitted to eight weeks of
training with weights (three times per week). Group A used 3 grams
of L-Arginine + vitamin C during the eight weeks and group B used
only vitamin C (control group). Results: After eight weeks of train-
ing, group A presented body weight values and lean mass signifi-
cantly higher (p < 0.05), body fat percentage significantly lower (p
< 0.05), and strength of lower limbs significantly higher (p < 0.05),
while group B did not present significant differences for the same
period. Conclusion: Oral administration of arginine associated with
a training program with weights increased the stimuli of the exer-
cise to the skeletal muscles level, enabling hence, increase of
muscular strength and mass.
INTRODUCTION
Oral administration of arginine has been related with improve-
ment of physical performance due to a probable decrease of mus-
cular fatigue. Such fact would be associated with the vasodilation
promoted by the nitric oxide, resulting in an increase of muscular
perfusion, as well as by the decrease of glucose consumption by
the skeletal muscles in activity(1). Nitric oxide (NO) is a molecular
gas which consists of the covalent ligation between a nitrogen
atom and an oxygen atom. Its production in the human body oc-
curs when the L-arginine amino acid is converted into L-citrulline in
a reaction catalyzed by the nitric oxide synthetase enzyme (NOS)(2).
Since prolonged administration of arginine increases the nitric ox-
ide production, its supplementation has been related with improve-
ment of contraction function of the skeletal muscle(3). Santos et al.
2001(4) demonstrated improvement of resistance to fatigue in indi-
viduals submitted to oral supplementation of arginine (3 g per day)
during 15 days.
On the other hand, arginine supplementation can also be asso-
ciated with improvement in contraction strength through greater
synthesis of muscular proteins(5) in periods of more prolonged ad-
ministration when concomitantly performed with a resisted-exer-
cises program. One may consider the hypothesis that the very ef-
fect of perfusion improvement of skeletal muscles contributes to
better quality of weight training. As a result to the prolonged time,
boosting of the training effects and more remarkable increase of
muscular mass and contraction strength are observed.
OBJECTIVE
This study had the aim to investigate the effects of the oral ad-
ministration of arginine during 8 weeks associated with a weight
exercises program.
METHODS
This study was approved by the Ethics Committee in Research
of the UNIFESP, under the resolution number 1188/06. The study’s
subjects signed the free and clarified consent form and 20 healthy
and non-smoker male individuals, age between 17 and 19 years
(mean 17.65 ± 0.8 years), were randomly divided in two groups
numerically equal: ARG and CON. They were submitted to eight
weeks of a weight training program for lower limbs, with frequen-
cy of three weekly sessions, intensity of 70 % of maximal load for
each muscular group, and training volume of three sets of ten rep-
etitions. The ARG group received oral supplementation of arginine
(three grams – single daily dose) associated with vitamin C (1 g/
day) and the CON group received only vitamin C (1 g/day).
Prior and post training program plus supplementation, the fol-
lowing variables were measured: weight (kg), muscular mass (Kg),
body fat % (Pollock) and bilateral muscular strength of knee flex-
extension (psi) in isokinetic dynamometer (BIODEX® USA).
Statistical analysis
– Paired ‘t’ test.
– ANOVA.
RESULTS
After eight weeks of weight training, we could observe that the
ARG group presented statistically significant increase of body
weight (66.4 ± 6.1 – 67.84 ± 6.8 Kg), and muscular mass (60.8 ±
6.05 – 62.07 ± 5.9 Kg) (figure 1) and decrease of fat mass (6.02 ±
0.6 – 5.77 ± 0.59 Kg) and body fat percentage (9.45 ± 0.8 – 8.66 ±
0.77) (figure 2), p < 0.05.
The CON group did not present significant differences (figures 3
and 4).
Concerning muscular strength for knee flexion and extension of
right (R) and left (L) legs, we could observe that the ARG group
presented post values significantly higher in both variables (Flex-
ion R 100.2 ± 9.4 – 108.8 ± 10.2; L 96.5 ± 9.3 – 103.3 ± 10.07;
Extension R 184.8 ± 17.4 – 195.8 ± 16.3; L 191.1 ± 18.4 – 199.1 ±
19.1) (figure 5) (p < 0.05).
Statistically significant differences were not observed for such
variables in the control group, which presented pre and post body
weight in Kg of 70.59 ± 6.88 and 70.9 ± 7.01 respectively; pre and
post lean mass in Kg of 64.88 ± 6.4 and 65.07 ± 6.7 respectively;
pre fat and post fat mass (Kg) 5.71 ± 0.4 and 5.83 ± 0.42 respec-
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tively; pre and post body fat percentage 8.06 ± 0.7 and 8.13 ± 0.73
respectively; and pre and post muscular strength (psi) of 129.9 ±
13.2 and 129.2 ± 12.9 for right knee flexion; 232 ± 20.01 and 221.5
± 22 for right knee extension, 114.2 ± 10.8 and 118.7 ± 11.2 for
left knee flexion; 222.3 ± 21.4 and 216.1 ± 20.2 for left knee ex-
tension, respectively (figure 6).
DISCUSSION
The effect of the oral administration of arginine in the strength
increase of lower limbs has been already reported(4). The hypothe-
sis which this increase occurs in short time has been related with
the vasodilator effect of nitric oxide, with consequent increase of
muscular perfusion. Schaefer et al. 2002(6) affirm in their study that
arginine supplementation favors the arginine-nitric oxide mecha-
nism triggered by physical exercise, increasing the formation of
nitric oxide from arginine.
However, it is also known that the arginine administration may
be related with a second effect associated with muscular strength
and mass, the protein synthesis(5).
The significant increases of lower limbs strength as well as lean
mass in the ARG group found in this study, suggest that the argin-
Figure 3 – Body weight and lean mass weight (Kg) pre and post 8 weeks




Figure 2 – Body fat percentage and fat mass (Kg) pre and post 8 weeks of
training in the individuals of the ARG group. The post body fat percentage
is significantly lower (p < 0.05).
ARG Group
PRE POST
Figure 5 – Maximal extension and flexion strength of the lower limbs pre
and post 8 weeks of training in the individuals of the ARG group. The post
values are significantly higher (p < 0.05).
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Figure 4 – Body fat percentage and fat mass (Kg) pre and post 8 weeks of




Figure 1 – Body weight and lean mass weight (Kg) pre and post 8 weeks
of training in individuals of the ARG group. The Post Weight and Lean
Mass values are significantly higher (p < 0.05).
ARG Group
PRE POST
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ine supplementation promoted greater increase of proteins syn-
thesis due to the interaction of its effects with resisted exercise
ones. This same effect at short term alone could partly answer for
the strength increase in isokinetic exercise obtained by Santos et
al. 2004(4). Moreover, the results of the present study corroborate
the findings by Flakoll et al. 2004(4) who when supplementing wom-
en with arginine for 12 weeks, found a significant increase in mus-
cular strength, lean mass, protein synthesis and functionality, reaf-
firming that arginine supplementation promotes protein synthesis,
resulting in strength and muscular mass increase.
The possible explanation for the lack of increase of muscular
mass and isokinetic strength of lower limbs in the individuals of
the control group must be related with the fact that this group did
not improve the weight training quality when associated only with
vitamin C ingestion. Since the training program performed during
the study’s period had already been applied to the athletes for a
previous time of 12 weeks, totalizing hence a period of 20 weeks
with no frequency, intensity and/or training volume alteration, it
would not be expected to find a very significant increase of mus-
cular strength or mass derived from it.
In addition, concerning the apparent strength difference between
the ARG and the CON groups, it was not statistically significant (p
> 0.05 single t test). Concerning strength in the isokinetic test, we
also observed a tendency in the control group to present higher
values which are not statistically significant either. Once strength
is expressed in absolute value, the tendency to heavier weight in
the CON group is reflected by a tendency of higher strength in
these individuals.
Apparently the oral administration of arginine is provided among
quality of training through three mechanisms interrelated and in-
terdependent simultaneously triggered by the vasodilation: the in-
crease of blood perfusion(7-9) – making the oxygen and nutrients
arrival to the tissues easier; greater glucose disposal for the mus-
cle in activity(8) – providing more energy substrate for the muscular
contraction; and the reduction of the plasma concentration of am-
monia and lactate(6) – delaying fatigue and decreasing the discom-
fort caused by the accumulation of these catabolites in the mus-
cles. This last idea takes grounding in the principle that first, the
accumulation of lactate is an indication of the glycogen depletion,
with high concentrations of lactate in the fatigue point(10-12); and
second, the lactic acid is the great responsible for the muscular
pain mentioned during exercise practice. Besides that, Yaspelkis
and Ivy 1999(13) affirm that arginine supplementation reduces the
oxidation of post-exercise carbohydrate being able thus to increase
the glucose availability for the reestablishment of muscular glyco-
gen supplies during recovery.
Smith, Smith and Criwell 2002(14) besides having demonstrated
the importance of nitric oxide for the muscular hypertrophy, also
evidenced its role as stimulator and booster for the transition be-
tween the two types of muscle fibers in overload situations. This
mechanism can be the responsible or booster of the muscular
strength increase found when arginine – precursor of nitric oxide –
is used in the present study.
A literature review conducted by Maréchal and Gailly 1999(15)
suggests that the nitric oxide effects over the muscle fibers may
be classified in two groups: direct action and mediated by the cy-
clic guanidine monophosphate (cGMP). In the former group, the
nitric oxide acts directly over the proteins leading to depression of
the isometric strength, decreasing the velocity of the resisted or
not resisted contractions, glycolysis and mitochondria breathing.
The effect over the release of the calcium channels varies, being
inhibiting in low and exciting in high concentrations. The general
consequence of the direct effects of the nitric oxide is the break of
the muscular contraction and its metabolism. In the latter group,
the NO effects are mediated by the cGMP – responsible for the
straight muscles relaxing, as well as for mediating the hormonal
effects (such as the growth hormone – GH), inhibiting the endot-
helium release (vasoconstrictor) and leading to velocity increase of
muscular shortening during contractions with or without overload;
maximal mechanical power; initial strength development; fusion
tetanic frequency; glucose consumption; glycolysis and the mito-
chondrial breathing; and decrease of the titanic relaxing and con-
traction and the calcium release stimulus-associated. All these ef-
fects have as consequence the increase of power and muscular
mechanics, similarly to the slow fibers transformation in fast ones.
Wang et al. 2001(16) found a severe and progressive reduction
over walk velocity, muscular mass as well as horizontal section
area of muscles of rats submitted to inhibition of the nitric oxide
synthetase (NOS).
The regeneration and growth of the muscle fibers injured during
physical activity depend on the cells activation-satellite. The genes
responsible for the production of these cells are activated between
3-6 hours after the beginning of the physical activity, and 3 extra
hours are needed so that the genes regulator of the muscular ac-
tivity are also expressed. The expression of these genes releases
the growth factor and, 24 hours later, activates the synthesis of
factors and muscular growth. Nitric oxide is responsible for medi-
ating the cells activation – satellite, accelerating the process(17).
Apparently, all the physical activity-related metabolic processes
are improved and boosted with the use of arginine, once better
blood perfusion at muscle level occurs, providing a greater release
of nutrients (the muscles are able to produce energy for a longer
time) and of oxygen (avoiding and/or delaying the anaerobioses
process); while they favor the clearance of toxic substances accu-
mulated during physical activity practice, making the muscular re-
covery process easier. Therefore, it seems important to associate
the arginine consumption to the resisted-exercises programs.
Nevertheless, there is still an issue to be better investigated. Is
there really an anabolic effect occasionally associated with greater
release of GH as a consequence of arginine supplementation, di-
rectly determining an increase of lean mass and a consequent
strength increase, or the arginine effect during 8 weeks of training
improved the training quality due to the perfusion increase, boost-
ing thus the exercise stimulus? Regardless of the answer, we con-
sider the increase of muscular mass obtained important, which
may actually provide an indication of arginine use not only in phys-
ical fitness programs but also in rehabilitation programs where the
increase of muscular mass becomes a priority.
Figure 6 – Maximal extension and flexion strength of the lower limbs pre
and post 8 weeks of training in the individuals of the control group. There
was no statistically significant difference.
Lower limbs strength
CON Group
RIGHT EXT LEFT EXT. RIGHT FLEX. LEFT FLEX.
PRE POST
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CONCLUSION
Oral administration of L-Arginine (3 g/day) seems to boost the
effects of weight training, providing greater strength and muscular
mass gain besides contributing to the decrease of body fat per-
centage.
All the authors declared there is not any potential conflict of inter-
ests regarding this article.
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